Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin‐1c

Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 243; no. 4; pp. 510 - 523
Main Authors Liu, Gang, Cooley, Marion A, Nair, Prema M, Donovan, Chantal, Hsu, Alan C, Jarnicki, Andrew G, Haw, Tatt Jhong, Hansbro, Nicole G, Ge, Qi, Brown, Alexandra C, Tay, Hock, Foster, Paul S, Wark, Peter A, Horvat, Jay C, Bourke, Jane E, Grainge, Chris L, Argraves, W Scott, Oliver, Brian G, Knight, Darryl A, Burgess, Janette K, Hansbro, Philip M
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.12.2017
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation of extracellular matrix (ECM) proteins, such as collagens. Fibulin‐1 (Fbln1) is an important ECM protein that stabilizes collagen and other ECM proteins. The level of Fbln1c, one of the four Fbln1 variants, which predominates in both humans and mice, is increased in the serum and airways fluids in asthma but its function is unclear. We show that the level of Fbln1c was increased in the lungs of mice with house dust mite (HDM)‐induced chronic allergic airway disease (AAD). Genetic deletion of Fbln1c and therapeutic inhibition of Fbln1c in mice with chronic AAD reduced airway collagen deposition, and protected against AHR. Fbln1c‐deficient (Fbln1c–/–) mice had reduced mucin (MUC) 5 AC levels, but not MUC5B levels, in the airways as compared with wild‐type (WT) mice. Fbln1c interacted with fibronectin and periostin that was linked to collagen deposition around the small airways. Fbln1c–/– mice with AAD also had reduced numbers of α‐smooth muscle actin‐positive cells around the airways and reduced airway contractility as compared with WT mice. After HDM challenge, these mice also had fewer airway inflammatory cells, reduced interleukin (IL)‐5, IL‐13, IL‐33, tumour necrosis factor (TNF) and CXCL1 levels in the lungs, and reduced IL‐5, IL‐33 and TNF levels in lung‐draining lymph nodes. Therapeutic targeting of Fbln1c reduced the numbers of GATA3‐positive Th2 cells in the lymph nodes and lungs after chronic HDM challenge. Treatment also reduced the secretion of IL‐5 and IL‐13 from co‐cultured dendritic cells and T cells restimulated with HDM extract. Human epithelial cells cultured with Fbln1c peptide produced more CXCL1 mRNA than medium‐treated controls. Our data show that Fbln1c may be a therapeutic target in chronic asthma. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
AbstractList Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation of extracellular matrix (ECM) proteins, such as collagens. Fibulin-1 (Fbln1) is an important ECM protein that stabilizes collagen and other ECM proteins. The level of Fbln1c, one of the four Fbln1 variants, which predominates in both humans and mice, is increased in the serum and airways fluids in asthma but its function is unclear. We show that the level of Fbln1c was increased in the lungs of mice with house dust mite (HDM)-induced chronic allergic airway disease (AAD). Genetic deletion of Fbln1c and therapeutic inhibition of Fbln1c in mice with chronic AAD reduced airway collagen deposition, and protected against AHR. Fbln1c-deficient (Fbln1c-/-) mice had reduced mucin (MUC) 5 AC levels, but not MUC5B levels, in the airways as compared with wild-type (WT) mice. Fbln1c interacted with fibronectin and periostin that was linked to collagen deposition around the small airways. Fbln1c-/- mice with AAD also had reduced numbers of [alpha]-smooth muscle actin-positive cells around the airways and reduced airway contractility as compared with WT mice. After HDM challenge, these mice also had fewer airway inflammatory cells, reduced interleukin (IL)-5, IL-13, IL-33, tumour necrosis factor (TNF) and CXCL1 levels in the lungs, and reduced IL-5, IL-33 and TNF levels in lung-draining lymph nodes. Therapeutic targeting of Fbln1c reduced the numbers of GATA3-positive Th2 cells in the lymph nodes and lungs after chronic HDM challenge. Treatment also reduced the secretion of IL-5 and IL-13 from co-cultured dendritic cells and T cells restimulated with HDM extract. Human epithelial cells cultured with Fbln1c peptide produced more CXCL1 mRNA than medium-treated controls. Our data show that Fbln1c may be a therapeutic target in chronic asthma. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation of extracellular matrix (ECM) proteins, such as collagens. Fibulin-1 (Fbln1) is an important ECM protein that stabilizes collagen and other ECM proteins. The level of Fbln1c, one of the four Fbln1 variants, which predominates in both humans and mice, is increased in the serum and airways fluids in asthma but its function is unclear. We show that the level of Fbln1c was increased in the lungs of mice with house dust mite (HDM)-induced chronic allergic airway disease (AAD). Genetic deletion of Fbln1c and therapeutic inhibition of Fbln1c in mice with chronic AAD reduced airway collagen deposition, and protected against AHR. Fbln1c-deficient (Fbln1c ) mice had reduced mucin (MUC) 5 AC levels, but not MUC5B levels, in the airways as compared with wild-type (WT) mice. Fbln1c interacted with fibronectin and periostin that was linked to collagen deposition around the small airways. Fbln1c mice with AAD also had reduced numbers of α-smooth muscle actin-positive cells around the airways and reduced airway contractility as compared with WT mice. After HDM challenge, these mice also had fewer airway inflammatory cells, reduced interleukin (IL)-5, IL-13, IL-33, tumour necrosis factor (TNF) and CXCL1 levels in the lungs, and reduced IL-5, IL-33 and TNF levels in lung-draining lymph nodes. Therapeutic targeting of Fbln1c reduced the numbers of GATA3-positive Th2 cells in the lymph nodes and lungs after chronic HDM challenge. Treatment also reduced the secretion of IL-5 and IL-13 from co-cultured dendritic cells and T cells restimulated with HDM extract. Human epithelial cells cultured with Fbln1c peptide produced more CXCL1 mRNA than medium-treated controls. Our data show that Fbln1c may be a therapeutic target in chronic asthma. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation of extracellular matrix (ECM) proteins, such as collagens. Fibulin‐1 (Fbln1) is an important ECM protein that stabilizes collagen and other ECM proteins. The level of Fbln1c, one of the four Fbln1 variants, which predominates in both humans and mice, is increased in the serum and airways fluids in asthma but its function is unclear. We show that the level of Fbln1c was increased in the lungs of mice with house dust mite (HDM)‐induced chronic allergic airway disease (AAD). Genetic deletion of Fbln1c and therapeutic inhibition of Fbln1c in mice with chronic AAD reduced airway collagen deposition, and protected against AHR. Fbln1c‐deficient (Fbln1c–/–) mice had reduced mucin (MUC) 5 AC levels, but not MUC5B levels, in the airways as compared with wild‐type (WT) mice. Fbln1c interacted with fibronectin and periostin that was linked to collagen deposition around the small airways. Fbln1c–/– mice with AAD also had reduced numbers of α‐smooth muscle actin‐positive cells around the airways and reduced airway contractility as compared with WT mice. After HDM challenge, these mice also had fewer airway inflammatory cells, reduced interleukin (IL)‐5, IL‐13, IL‐33, tumour necrosis factor (TNF) and CXCL1 levels in the lungs, and reduced IL‐5, IL‐33 and TNF levels in lung‐draining lymph nodes. Therapeutic targeting of Fbln1c reduced the numbers of GATA3‐positive Th2 cells in the lymph nodes and lungs after chronic HDM challenge. Treatment also reduced the secretion of IL‐5 and IL‐13 from co‐cultured dendritic cells and T cells restimulated with HDM extract. Human epithelial cells cultured with Fbln1c peptide produced more CXCL1 mRNA than medium‐treated controls. Our data show that Fbln1c may be a therapeutic target in chronic asthma. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway hyperresponsiveness (AHR). Asthma patients, in particular those with chronic or severe asthma, have airway remodelling that is associated with the accumulation of extracellular matrix (ECM) proteins, such as collagens. Fibulin-1 (Fbln1) is an important ECM protein that stabilizes collagen and other ECM proteins. The level of Fbln1c, one of the four Fbln1 variants, which predominates in both humans and mice, is increased in the serum and airways fluids in asthma but its function is unclear. We show that the level of Fbln1c was increased in the lungs of mice with house dust mite (HDM)-induced chronic allergic airway disease (AAD). Genetic deletion of Fbln1c and therapeutic inhibition of Fbln1c in mice with chronic AAD reduced airway collagen deposition, and protected against AHR. Fbln1c-deficient (Fbln1c-/- ) mice had reduced mucin (MUC) 5 AC levels, but not MUC5B levels, in the airways as compared with wild-type (WT) mice. Fbln1c interacted with fibronectin and periostin that was linked to collagen deposition around the small airways. Fbln1c-/- mice with AAD also had reduced numbers of α-smooth muscle actin-positive cells around the airways and reduced airway contractility as compared with WT mice. After HDM challenge, these mice also had fewer airway inflammatory cells, reduced interleukin (IL)-5, IL-13, IL-33, tumour necrosis factor (TNF) and CXCL1 levels in the lungs, and reduced IL-5, IL-33 and TNF levels in lung-draining lymph nodes. Therapeutic targeting of Fbln1c reduced the numbers of GATA3-positive Th2 cells in the lymph nodes and lungs after chronic HDM challenge. Treatment also reduced the secretion of IL-5 and IL-13 from co-cultured dendritic cells and T cells restimulated with HDM extract. Human epithelial cells cultured with Fbln1c peptide produced more CXCL1 mRNA than medium-treated controls. Our data show that Fbln1c may be a therapeutic target in chronic asthma. Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Author Liu, Gang
Argraves, W Scott
Donovan, Chantal
Ge, Qi
Hansbro, Philip M
Cooley, Marion A
Jarnicki, Andrew G
Hansbro, Nicole G
Foster, Paul S
Hsu, Alan C
Horvat, Jay C
Brown, Alexandra C
Burgess, Janette K
Grainge, Chris L
Haw, Tatt Jhong
Bourke, Jane E
Wark, Peter A
Knight, Darryl A
Oliver, Brian G
Nair, Prema M
Tay, Hock
Author_xml – sequence: 1
  givenname: Gang
  surname: Liu
  fullname: Liu, Gang
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 2
  givenname: Marion A
  surname: Cooley
  fullname: Cooley, Marion A
  organization: Medical University of South Carolina
– sequence: 3
  givenname: Prema M
  surname: Nair
  fullname: Nair, Prema M
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 4
  givenname: Chantal
  surname: Donovan
  fullname: Donovan, Chantal
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 5
  givenname: Alan C
  surname: Hsu
  fullname: Hsu, Alan C
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 6
  givenname: Andrew G
  surname: Jarnicki
  fullname: Jarnicki, Andrew G
  organization: University of Melbourne
– sequence: 7
  givenname: Tatt Jhong
  surname: Haw
  fullname: Haw, Tatt Jhong
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 8
  givenname: Nicole G
  orcidid: 0000-0002-4741-3035
  surname: Hansbro
  fullname: Hansbro, Nicole G
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 9
  givenname: Qi
  surname: Ge
  fullname: Ge, Qi
  organization: University of Sydney
– sequence: 10
  givenname: Alexandra C
  surname: Brown
  fullname: Brown, Alexandra C
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 11
  givenname: Hock
  surname: Tay
  fullname: Tay, Hock
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 12
  givenname: Paul S
  surname: Foster
  fullname: Foster, Paul S
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 13
  givenname: Peter A
  surname: Wark
  fullname: Wark, Peter A
  organization: John Hunter Hospital
– sequence: 14
  givenname: Jay C
  surname: Horvat
  fullname: Horvat, Jay C
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 15
  givenname: Jane E
  surname: Bourke
  fullname: Bourke, Jane E
  organization: Monash University
– sequence: 16
  givenname: Chris L
  surname: Grainge
  fullname: Grainge, Chris L
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 17
  givenname: W Scott
  surname: Argraves
  fullname: Argraves, W Scott
  organization: Medical University of South Carolina
– sequence: 18
  givenname: Brian G
  surname: Oliver
  fullname: Oliver, Brian G
  organization: University of Technology Sydney
– sequence: 19
  givenname: Darryl A
  surname: Knight
  fullname: Knight, Darryl A
  organization: Hunter Medical Research Institute and The University of Newcastle
– sequence: 20
  givenname: Janette K
  surname: Burgess
  fullname: Burgess, Janette K
  organization: Groningen Research Institute of Asthma and COPD
– sequence: 21
  givenname: Philip M
  surname: Hansbro
  fullname: Hansbro, Philip M
  email: philip.hansbro@newcastle.edu.au
  organization: Hunter Medical Research Institute and The University of Newcastle
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28862768$$D View this record in MEDLINE/PubMed
BookMark eNpdkU1OwzAQhS0EoqWw4ALIEhs2oXYcO_GyQvxJlWBR1tEknlBXiVOcRNAdR-CMnARH_CzY2B69b0Zv_I7IvmsdEnLK2SVnLJ5voV9fJjrVe2TKmVaRzrTaJ9OgxZFIeDohR123YYxpLeUhmcRZpuJUZVNSL6x_hR312LQG69q6ZwrOUOuqGpoGetu6UFDo-nUDFDxSg1t0Bl1Pg9SvkeJb76EMzUMNnoYeb9_o1rc9hsbKFkOY-vn-wctjclBB3eHJzz0jTzfXq6u7aPlwe3-1WEalkImOsEwFM5CocBZoTCFKzNJC8QLSatygKlBKLMLCnCUpVDJLAeOqZMBNzLmYkYvvucHEy4Bdnze2Gw2Cw3bocq6F4kroOA7o-T900w7eBXeBUpJLITMRqLMfaigaNPnW2wb8Lv_9xwDMv4FXW-PuT-csHwPKx4DyMaD8cbG6Gx_iC7f0h0Y
CitedBy_id crossref_primary_10_1016_j_trre_2021_100626
crossref_primary_10_1016_j_cej_2022_138292
crossref_primary_10_1186_s12931_020_01445_6
crossref_primary_10_3389_fphar_2021_645858
crossref_primary_10_3389_fphys_2021_690531
crossref_primary_10_1016_j_biopha_2023_115995
crossref_primary_10_3389_fcvm_2022_872446
crossref_primary_10_1002_path_5401
crossref_primary_10_1038_s41385_020_00340_z
crossref_primary_10_1038_s41467_023_41381_9
crossref_primary_10_1007_s10753_021_01494_z
crossref_primary_10_1096_fj_201901779R
crossref_primary_10_3389_fphar_2018_00859
crossref_primary_10_1093_jpp_rgae064
crossref_primary_10_1002_jcla_23764
crossref_primary_10_1016_j_jconrel_2020_10_061
crossref_primary_10_1183_16000617_0096_2019
crossref_primary_10_3389_fphys_2023_1099719
crossref_primary_10_1016_j_cca_2021_02_012
crossref_primary_10_1186_s12885_020_6686_x
crossref_primary_10_1038_s41385_019_0163_3
crossref_primary_10_1183_16000617_0185_2019
crossref_primary_10_1183_16000617_0202_2021
crossref_primary_10_1038_s41433_022_02318_6
crossref_primary_10_1155_2019_3638469
crossref_primary_10_1016_j_ajpath_2018_03_016
crossref_primary_10_1080_21655979_2022_2036890
crossref_primary_10_1186_s12931_023_02313_9
crossref_primary_10_1183_13993003_01340_2019
crossref_primary_10_1016_j_matbio_2018_03_012
crossref_primary_10_1016_j_pharmthera_2021_107839
crossref_primary_10_3390_ijms20164037
crossref_primary_10_1111_cea_14013
crossref_primary_10_1002_med_21956
crossref_primary_10_1016_j_intimp_2020_107289
crossref_primary_10_1183_13993003_01431_2021
crossref_primary_10_1016_j_bbrc_2020_11_027
crossref_primary_10_3389_fcvm_2021_674498
crossref_primary_10_1007_s10787_020_00770_y
crossref_primary_10_1111_all_15473
crossref_primary_10_1183_13993003_04361_2020
crossref_primary_10_1089_ars_2019_7818
crossref_primary_10_1155_2019_7930396
crossref_primary_10_1007_s11356_022_21454_w
crossref_primary_10_1515_cclm_2022_1323
crossref_primary_10_1016_j_jaci_2021_05_042
crossref_primary_10_1016_j_mcpro_2024_100794
crossref_primary_10_1038_s41467_023_42913_z
crossref_primary_10_1002_ptr_6067
crossref_primary_10_3389_fphar_2022_865097
crossref_primary_10_1016_j_biopha_2021_112189
crossref_primary_10_1016_j_jaci_2022_04_032
crossref_primary_10_1016_j_intimp_2021_107637
crossref_primary_10_3389_fonc_2021_754240
crossref_primary_10_1016_j_matbio_2017_12_004
crossref_primary_10_1089_jir_2021_0189
crossref_primary_10_1186_s12931_022_02298_x
crossref_primary_10_1186_s12951_019_0478_y
crossref_primary_10_1002_tox_23311
crossref_primary_10_1155_2021_4080935
crossref_primary_10_4269_ajtmh_20_0484
crossref_primary_10_1152_ajplung_00232_2022
crossref_primary_10_1039_C9FO00896A
crossref_primary_10_1183_16000617_0186_2020
crossref_primary_10_1016_j_redox_2020_101720
crossref_primary_10_1186_s10020_020_00169_z
crossref_primary_10_1002_cti2_1084
crossref_primary_10_1172_jci_insight_124529
crossref_primary_10_3390_ijms21030757
crossref_primary_10_1016_j_bbrc_2021_07_023
crossref_primary_10_3390_ijms242216042
ContentType Journal Article
Copyright Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Copyright © 2017 Pathological Society of Great Britain and Ireland
Copyright_xml – notice: Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
– notice: Copyright © 2017 Pathological Society of Great Britain and Ireland
DBID CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
FR3
H94
K9.
P64
RC3
7X8
DOI 10.1002/path.4979
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Calcium & Calcified Tissue Abstracts
Chemoreception Abstracts
Immunology Abstracts
Neurosciences Abstracts
Nucleic Acids Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Engineering Research Database
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Oncogenes and Growth Factors Abstracts
Technology Research Database
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Chemoreception Abstracts
Immunology Abstracts
Engineering Research Database
Calcium & Calcified Tissue Abstracts
Neurosciences Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList Genetics Abstracts
MEDLINE

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1096-9896
EndPage 523
ExternalDocumentID 28862768
PATH4979
Genre article
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations United Kingdom--UK
Ireland
GeographicLocations_xml – name: Ireland
– name: United Kingdom--UK
GrantInformation_xml – fundername: Rosalind Franklin Fellowship
– fundername: National Health and Medical Research Council
– fundername: University of Groningen and the European Union
GroupedDBID ---
-~X
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
123
1KJ
1L6
1OB
1OC
1ZS
29L
31~
33P
3O-
3SF
3UE
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABLJU
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACFBH
ACGFS
ACGOF
ACIWK
ACMXC
ACPOU
ACPRK
ACSCC
ACXBN
ACXQS
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFNX
AFFPM
AFGKR
AFPWT
AFRAH
AFZJQ
AHBTC
AHMBA
AI.
AIACR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CS3
D-6
D-7
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
EBS
EJD
EMOBN
F00
F01
F04
F5P
FEDTE
FUBAC
G-S
G.N
GNP
GODZA
GSXLS
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
J5H
JPC
KBYEO
KQQ
L7B
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M68
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MVM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OHT
OIG
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RWI
RX1
SAMSI
SUPJJ
SV3
TEORI
UB1
V2E
VH1
W8V
W99
WBKPD
WH7
WHWMO
WIB
WIH
WIJ
WIK
WJL
WOHZO
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
XPP
XV2
YQI
YQJ
ZGI
ZXP
ZZTAW
~IA
~KM
~WT
CGR
CUY
CVF
ECM
EIF
NPM
7QP
7QR
7T5
7TK
7TM
7TO
8FD
AAMNL
FR3
H94
K9.
P64
RC3
7X8
ID FETCH-LOGICAL-c3549-ec730da4630dbeddb3ce87b61ba7f9955fbe55eb9791047af587ae2fc0a1d2113
IEDL.DBID DR2
ISSN 0022-3417
IngestDate Wed Dec 04 06:51:18 EST 2024
Sun Nov 24 08:17:55 EST 2024
Sat Sep 28 08:31:55 EDT 2024
Sat Aug 24 01:02:08 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords allergic airway disease
airway hyperresponsiveness
fibulin-1
lung function
inflammation
airway remodelling
collagen
asthma
fibrosis
Language English
License Copyright © 2017 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3549-ec730da4630dbeddb3ce87b61ba7f9955fbe55eb9791047af587ae2fc0a1d2113
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0002-4741-3035
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/path.4979
PMID 28862768
PQID 1965153583
PQPubID 1006392
PageCount 14
ParticipantIDs proquest_miscellaneous_1936163922
proquest_journals_1965153583
pubmed_primary_28862768
wiley_primary_10_1002_path_4979_PATH4979
PublicationCentury 2000
PublicationDate December 2017
2017-12-00
20171201
PublicationDateYYYYMMDD 2017-12-01
PublicationDate_xml – month: 12
  year: 2017
  text: December 2017
PublicationDecade 2010
PublicationPlace Chichester, UK
PublicationPlace_xml – name: Chichester, UK
– name: England
– name: Bognor Regis
PublicationTitle The Journal of pathology
PublicationTitleAlternate J Pathol
PublicationYear 2017
Publisher John Wiley & Sons, Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Ltd
– name: Wiley Subscription Services, Inc
References 2015; 34
2007; 101
2005; 174
2013; 22
2010; 107
2015; 70
1997; 272
1977; 20
2008; 5
2010; 184
2011; 56
1996; 148
2013; 6
2003; 111
2016; 35
2014; 134
1994; 145
2010; 65
2012; 130
1987; 42
1990; 259
2013; 14
2013; 13
2013; 710
2009; 123
2002; 346
2009; 360
2011; 163
2009; 19
2012; 67
2010; 5
2014; 7
2014; 50
2008; 153
2014; 289
2002; 39
2015; 6
2012; 188
2015; 5
2015; 16
2001; 164
2015; 53
1992; 267
2014; 151
2011; 37
2014; 193
2006; 116
2014; 44
2017; 139
2004; 10
2015; 191
2016; 1
2004; 114
2004; 113
2000; 106
2002; 122
2010; 299
1995; 43
2009; 183
2013; 132
2005; 15
2008; 177
2012; 7
1990; 111
2011; 144
2016; 9
2001; 114
2016; 173
References_xml – volume: 37
  start-page: 53
  year: 2011
  end-page: 64
  article-title: Streptococcus pneumoniae infection suppresses allergic airways disease by inducing regulatory T‐cells
  publication-title: Eur Respir J
– volume: 174
  start-page: 2258
  year: 2005
  end-page: 2264
  article-title: Multiple beta 1 integrins mediate enhancement of human airway smooth muscle cytokine secretion by fibronectin and type I collagen
  publication-title: J Immunol
– volume: 346
  start-page: 1699
  year: 2002
  end-page: 1705
  article-title: Mast‐cell infiltration of airway smooth muscle in asthma
  publication-title: N Engl J Med
– volume: 272
  year: 1997
  end-page: 22606
  article-title: The self‐association and fibronectin‐binding sites of fibulin‐1 map to calcium‐binding epidermal growth factor‐like domains
  publication-title: J Biol Chem
– volume: 15
  start-page: 483
  year: 2005
  end-page: 494
  article-title: The interaction of versican with its binding partners
  publication-title: Cell Res
– volume: 289
  year: 2014
  end-page: 18227
  article-title: Importance of mast cell Prss31/transmembrane tryptase/tryptase‐gamma in lung function and experimental chronic obstructive pulmonary disease and colitis
  publication-title: J Biol Chem
– volume: 34
  start-page: 1006
  year: 2015
  end-page: 1018
  article-title: Extracellular calumenin suppresses ERK1/2 signaling and cell migration by protecting fibulin‐1 from MMP‐13‐mediated proteolysis
  publication-title: Oncogene
– volume: 360
  start-page: 1002
  year: 2009
  end-page: 1014
  article-title: Asthma
  publication-title: N Engl J Med
– volume: 107
  year: 2010
  end-page: 14175
  article-title: Roles of epithelial cell‐derived periostin in TGF‐beta activation, collagen production, and collagen gel elasticity in asthma
  publication-title: Proc Natl Acad Sci U S A
– volume: 139
  start-page: 519
  year: 2017
  end-page: 532
  article-title: MicroRNA‐21 drives severe, steroid‐insensitive experimental asthma by amplifying phosphoinositide 3‐kinase‐mediated suppression of histone deacetylase 2
  publication-title: J Allergy Clin Immunol
– volume: 42
  start-page: 361
  year: 1987
  end-page: 368
  article-title: Prevalence of bronchial hyperresponsiveness and asthma in a rural adult population
  publication-title: Thorax
– volume: 56
  start-page: 823
  year: 2011
  end-page: 831
  article-title: Bronchial epithelial cells release IL‐6, CXCL1 and CXCL8 upon mast cell interaction
  publication-title: Cytokine
– volume: 44
  start-page: 381
  year: 2014
  end-page: 392
  article-title: CXCL1 is a negative regulator of mast cell chemotaxis to airway smooth muscle cell products in vitro
  publication-title: Clin Exp Allergy
– volume: 7
  year: 2012
  article-title: Chlamydia muridarum lung infection in infants alters hematopoietic cells to promote allergic airway disease in mice
  publication-title: PLoS One
– volume: 188
  start-page: 4611
  year: 2012
  end-page: 4620
  article-title: Components of Streptococcus pneumoniae suppress allergic airways disease and NKT cells by inducing regulatory T cells
  publication-title: J Immunol
– volume: 148
  start-page: 527
  year: 1996
  end-page: 537
  article-title: Lung fibroblast alpha‐smooth muscle actin expression and contractile phenotype in bleomycin‐induced pulmonary fibrosis
  publication-title: Am J Pathol
– volume: 114
  start-page: 4587
  year: 2001
  end-page: 4598
  article-title: Fibulin‐1 suppression of fibronectin‐regulated cell adhesion and motility
  publication-title: J Cell Sci
– volume: 111
  start-page: 3155
  year: 1990
  end-page: 3164
  article-title: Fibulin is an extracellular matrix and plasma glycoprotein with repeated domain structure
  publication-title: J Cell Biol
– volume: 113
  start-page: 690
  year: 2004
  end-page: 696
  article-title: Extracellular matrix proteins modulate asthmatic airway smooth muscle cell proliferation via an autocrine mechanism
  publication-title: J Allergy Clin Immunol
– volume: 163
  start-page: 81
  year: 2011
  end-page: 95
  article-title: Cytokine/anti‐cytokine therapy – novel treatments for asthma?
  publication-title: Br J Pharmacol
– volume: 153
  start-page: 12
  year: 2008
  end-page: 16
  article-title: Allergy and the lung
  publication-title: Clin Exp Immunol
– volume: 65
  start-page: 1053
  year: 2010
  end-page: 1060
  article-title: Pneumococcal conjugate vaccine‐induced regulatory T cells suppress the development of allergic airways disease
  publication-title: Thorax
– volume: 111
  start-page: 1293
  year: 2003
  end-page: 1298
  article-title: Airway remodeling‐associated mediators in moderate to severe asthma: effect of steroids on TGF‐beta, IL‐11, IL‐17, and type I and type III collagen expression
  publication-title: J Allergy Clin Immunol
– volume: 145
  start-page: 868
  year: 1994
  end-page: 875
  article-title: The alpha‐smooth muscle actin‐positive cells in healing human myocardial scars
  publication-title: Am J Pathol
– volume: 6
  start-page: 6281
  year: 2015
  article-title: The polymeric mucin Muc5ac is required for allergic airway hyperreactivity
  publication-title: Nat Commun
– volume: 710
  start-page: 100
  year: 2013
  end-page: 109
  article-title: Bradykinin‐induced asthmatic fibroblast/myofibroblast activities via bradykinin B2 receptor and different MAPK pathways
  publication-title: Eur J Pharmacol
– volume: 1
  year: 2016
  article-title: Fibulin‐1 regulates the pathogenesis of tissue remodeling in respiratory diseases
  publication-title: JCI Insight
– volume: 134
  start-page: 1433
  year: 2014
  end-page: 1442
  article-title: Periostin is required for maximal airways inflammation and hyperresponsiveness in mice
  publication-title: J Allergy Clin Immunol
– volume: 173
  start-page: 3161
  year: 2016
  end-page: 3175
  article-title: The inhibitor of semicarbazide-sensitive amino oxidase, PXS-4728A, ameliorates key features of chronic obstructive pulmonary disease in a mouse model
  publication-title: Br J Pharmacol
– volume: 5
  start-page: 9496
  year: 2015
  article-title: Fibulin1C peptide induces cell attachment and extracellular matrix deposition in lung fibroblasts
  publication-title: Sci Rep
– volume: 299
  start-page: L785
  year: 2010
  end-page: L793
  article-title: Tenascin‐C deficiency attenuates TGF‐ss‐mediated fibrosis following murine lung injury
  publication-title: Am J Physiol Lung Cell Mol Physiol
– volume: 43
  start-page: 401
  year: 1995
  end-page: 411
  article-title: The association of human fibulin‐1 with elastic fibers: an immunohistological, ultrastructural, and RNA study
  publication-title: J Histochem Cytochem
– volume: 9
  start-page: 859
  year: 2016
  end-page: 872
  article-title: A pathogenic role for tumor necrosis factor‐related apoptosis‐inducing ligand in chronic obstructive pulmonary disease
  publication-title: Mucosal Immunol
– volume: 22
  start-page: 49
  year: 2013
  end-page: 69
  article-title: Th2 cytokine antagonists: potential treatments for severe asthma
  publication-title: Expert Opin Investig Drugs
– volume: 184
  start-page: 4159
  year: 2010
  end-page: 4169
  article-title: Chlamydial respiratory infection during allergen sensitization drives neutrophilic allergic airways disease
  publication-title: J Immunol
– volume: 10
  start-page: 193
  year: 2004
  end-page: 196
  article-title: A MARCKS‐related peptide blocks mucus hypersecretion in a mouse model of asthma
  publication-title: Nat Med
– volume: 20
  issue: 1
  year: 1977
  end-page: 5
  article-title: Binding of soluble form of fibroblast surface protein, fibronectin, to collagen
  publication-title: Int J Cancer
– volume: 123
  start-page: 1090
  year: 2009
  end-page: 1097
  article-title: The outer wall of small airways is a major site of remodeling in fatal asthma
  publication-title: J Allergy Clin Immunol
– volume: 5
  start-page: 89
  year: 2008
  end-page: 96
  article-title: Airway smooth muscle growth in asthma: proliferation, hypertrophy, and migration
  publication-title: Proc Am Thorac Soc
– volume: 7
  year: 2012
  article-title: Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection
  publication-title: PLoS One
– volume: 193
  start-page: 1416
  year: 2014
  end-page: 1426
  article-title: CXCL1 inhibits airway smooth muscle cell migration through the decoy receptor Duffy antigen receptor for chemokines
  publication-title: J Immunol
– volume: 177
  start-page: 593
  year: 2008
  end-page: 603
  article-title: Transforming growth factor‐beta regulates house dust mite‐induced allergic airway inflammation but not airway remodeling
  publication-title: Am J Respir Crit Care Med
– volume: 35
  start-page: 1899
  year: 2016
  end-page: 1908
  article-title: Integrin alpha11beta1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non‐small cell lung cancer
  publication-title: Oncogene
– volume: 106
  start-page: 1341
  year: 2000
  end-page: 1350
  article-title: Bleomycin‐induced pulmonary fibrosis in fibrinogen‐null mice
  publication-title: J Clin Invest
– volume: 39
  start-page: 258
  year: 2002
  end-page: 263
  article-title: Stimulation of collagen production by transforming growth factor‐beta1 during differentiation of cardiac fibroblasts to myofibroblasts
  publication-title: Hypertension
– volume: 130
  start-page: 647
  year: 2012
  article-title: Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients
  publication-title: J Allergy Clin Immunol
– volume: 70
  start-page: 458
  year: 2015
  end-page: 467
  article-title: Macrolide therapy suppresses key features of experimental steroid‐sensitive and steroid‐insensitive asthma
  publication-title: Thorax
– volume: 144
  start-page: 577
  year: 2011
  end-page: 589
  article-title: The basement membrane of hair follicle stem cells is a muscle cell niche
  publication-title: Cell
– volume: 19
  start-page: 511
  year: 2009
  end-page: 519
  article-title: Tenascins and their implications in diseases and tissue mechanics
  publication-title: Scand J Med Sci Sports
– volume: 259
  start-page: L159
  year: 1990
  end-page: L184
  article-title: Pathobiology of pulmonary fibrosis
  publication-title: Am J Physiol
– volume: 13
  start-page: 337
  year: 2013
  end-page: 344
  article-title: Murine models of infectious exacerbations of airway inflammation
  publication-title: Curr Opin Pharmacol
– volume: 67
  start-page: 835
  year: 2012
  end-page: 846
  article-title: Untangling asthma phenotypes and endotypes
  publication-title: Allergy
– volume: 7
  start-page: 478
  year: 2014
  end-page: 488
  article-title: Tumor necrosis factor‐related apoptosis‐inducing ligand translates neonatal respiratory infection into chronic lung disease
  publication-title: Mucosal Immunol
– volume: 101
  start-page: 695
  year: 2007
  end-page: 711
  article-title: Periostin regulates collagen fibrillogenesis and the biomechanical properties of connective tissues
  publication-title: J Cell Biochem
– volume: 267
  start-page: 20120
  year: 1992
  end-page: 20125
  article-title: Fibulin binds to itself and to the carboxyl‐terminal heparin‐binding region of fibronectin
  publication-title: J Biol Chem
– volume: 50
  start-page: 748
  year: 2014
  end-page: 756
  article-title: Novel small airway bronchodilator responses to rosiglitazone in mouse lung slices
  publication-title: Am J Respir Cell Mol Biol
– volume: 14
  start-page: 135
  year: 2013
  article-title: Generation of a human airway epithelium derived basal cell line with multipotent differentiation capacity
  publication-title: Respir Res
– volume: 164
  start-page: 474
  year: 2001
  end-page: 477
  article-title: Airway smooth muscle cell proliferation is increased in asthma
  publication-title: Am J Respir Crit Care Med
– volume: 122
  start-page: 286S
  year: 2002
  end-page: 289S
  article-title: The myofibroblast in pulmonary fibrosis
  publication-title: Chest
– volume: 67
  start-page: 588
  year: 2012
  end-page: 599
  article-title: Combined Haemophilus influenzae respiratory infection and allergic airways disease drives chronic infection and features of neutrophilic asthma
  publication-title: Thorax
– volume: 151
  year: 2014
  article-title: Airway epithelial regulation of pulmonary immune homeostasis and inflammation
  publication-title: Clin Immunol
– volume: 183
  start-page: 6469
  year: 2009
  end-page: 6477
  article-title: IL‐33 amplifies the polarization of alternatively activated macrophages that contribute to airway inflammation
  publication-title: J Immunol
– volume: 5
  year: 2010
  article-title: Fibulin‐1 is increased in asthma – a novel mediator of airway remodeling?
  publication-title: PLoS One
– volume: 16
  start-page: 21
  year: 2015
  article-title: Fibroblast–myofibroblast transition is differentially regulated by bronchial epithelial cells from asthmatic children
  publication-title: Respir Res
– volume: 6
  start-page: 569
  year: 2013
  end-page: 579
  article-title: Constitutive production of IL‐13 promotes early‐life Chlamydia respiratory infection and allergic airway disease
  publication-title: Mucosal Immunol
– volume: 191
  start-page: 1012
  year: 2015
  end-page: 1023
  article-title: Targeting PI3K‐p110alpha suppresses influenza virus infection in chronic obstructive pulmonary disease
  publication-title: Am J Respir Crit Care Med
– volume: 114
  start-page: S32
  year: 2004
  end-page: S50
  article-title: Synthetic responses in airway smooth muscle
  publication-title: J Allergy Clin Immunol
– volume: 132
  start-page: 676
  year: 2013
  article-title: IL‐33 promotes airway remodeling in pediatric patients with severe steroid‐resistant asthma
  publication-title: J Allergy Clin Immunol
– volume: 116
  start-page: 306
  year: 2006
  end-page: 308
  article-title: Mucus in chronic airway diseases: sorting out the sticky details
  publication-title: J Clin Invest
– volume: 53
  start-page: 471
  year: 2015
  end-page: 478
  article-title: Alteration of airway reactivity and reduction of ryanodine receptor expression by cigarette smoke in mice
  publication-title: Am J Respir Cell Mol Biol
SSID ssj0009955
Score 2.5619547
Snippet Asthma is a chronic inflammatory disease of the airways. It is characterized by allergic airway inflammation, airway remodelling, and airway...
SourceID proquest
pubmed
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage 510
SubjectTerms Actin
Actins - metabolism
airway hyperresponsiveness
Airway Remodeling
airway remodelling
allergic airway disease
Animals
Asthma
Asthma - immunology
Asthma - metabolism
Asthma - physiopathology
Asthma - prevention & control
Bronchial Hyperreactivity - immunology
Bronchial Hyperreactivity - metabolism
Bronchial Hyperreactivity - physiopathology
Bronchial Hyperreactivity - prevention & control
Bronchoconstriction
Calcium-Binding Proteins - deficiency
Calcium-Binding Proteins - genetics
Calcium-Binding Proteins - metabolism
Cells, Cultured
Clonal deletion
Coculture Techniques
Collagen
Cytokines - genetics
Cytokines - metabolism
Dendritic cells
Disease Models, Animal
Epithelial cells
Extracellular matrix
Extracellular Matrix Proteins - deficiency
Extracellular Matrix Proteins - genetics
Extracellular Matrix Proteins - metabolism
Female
Fibronectin
fibrosis
fibulin‐1
GATA-3 protein
Genotype
Helper cells
House dust
Humans
inflammation
Inflammation - immunology
Inflammation - metabolism
Inflammation - physiopathology
Inflammation - prevention & control
Inflammation Mediators - metabolism
Interleukin 13
Interleukin 5
Lung - immunology
Lung - metabolism
Lung - physiopathology
lung function
Lungs
Lymph nodes
Lymph Nodes - immunology
Lymph Nodes - metabolism
Lymphatic system
Lymphocytes
Lymphocytes T
Matrix protein
Mice
Mice, Inbred C57BL
Mice, Knockout
mRNA
Mucin
Muscle contraction
Phenotype
Proteins
Respiratory tract diseases
RNA Interference
Rodents
Signal Transduction
Smooth muscle
T-Lymphocytes - immunology
T-Lymphocytes - metabolism
Therapeutic targets
Time Factors
Transfection
Tumor necrosis factor
Tumor necrosis factor-TNF
Tumors
Title Airway remodelling and inflammation in asthma are dependent on the extracellular matrix protein fibulin‐1c
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fpath.4979
https://www.ncbi.nlm.nih.gov/pubmed/28862768
https://www.proquest.com/docview/1965153583
https://search.proquest.com/docview/1936163922
Volume 243
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NS91AEB_EQ_FiP7WvatlCD17yfNlssgk9PWzlUVCKKHgohNkvFGsseXmoPfVP6N_Yv6QzyUukxYP0EhJ2N-xmPnYmO_MbgPdoC4UmZ-RHrSNl0UVGhiyySebJe1C-8JyNfHiUzU7V57P0bAU-9LkwHT7E8MONJaPV1yzgaOZ796ChXLF3rArNyXtxojmc7-PxPXRUUaTpgBSuYt2jCk3k3jDyIavybyO13WUOnsLXfn5dcMnleNGYsf3xD3Tjfy7gGawvrU8x7djlOaz46gU8OVyer7-Eb9OL-gbvRO3bCjmcqi6wcoLYkDiny3KkB4Hz5vwKBdZe9FV0G0FNZE0K0vY18nkAB7iKKy4BcCtaOAgaGC4Mh77__vkrtq_g9ODTyf4sWtZjIMqRGxl5S-rAocroarxzJrE-1yaLDerA3zsYn6be0JIYAAJDmmv0MtgJxo4czWQDVqvryr8GESZoY-usjp1SgV6QuoBYqMxJp4ycjGC7p0y5FKp5yeCHpKDTPBnBu6GZxIHXhJW_XnCfJCMTs5ByBJsdRcvvHW5HKXNy38i9GsFuS5ehoYNuliVTpGSKlF-mJzO-efP4rluwJnnLb0NdtmG1qRd-hwyWxrxtOfMPLsfsAg
link.rule.ids 314,780,784,1375,27924,27925,46294,46718
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dT9RAEJ8gJMqL4gd6CLgmPvjS47rdfiW-XFByKkeMORJeTDP7FYhQTOlF5ck_wb_Rv4SZ9lqC4cH40rTZ3Wa389GZ3ZnfALxCkyvUGSM_pmmgDNpAS58EJkoceQ_K5Y6zkacHyeRQfTiKj5bgTZcL0-JD9BtuLBmNvmYB5w3pnWvUUC7ZO1R5mt-BFRL3kAO63n6-Bo_K8zjuscJVmHa4QiO50w-9za68aaY2_5m9B_Clm2EbXvJ1OK_10Fz-Bd74v0tYg_sLA1SMW455CEuufAR3p4sj9sdwOj6pvuNPUbmmSA5nqwssrSBOJOZpEx3pQeBFfXyGAisnukK6taAmMigFKfwK-UiAY1zFGVcB-CEaRAga6E80R7__-fU7NE_gcO_dbHcSLEoyEPHIkwycIY1gUSV01c5aHRmXpToJNaaeP7jXLo6dpiUxBgT6OEvRSW9GGFryNaN1WC7PS_cMhB-hCY01aWiV8vSC2HrEXCVWWqXlaACbHWmKhVxdFIx_SDo6zqIBvOybSSJ4TVi68zn3iRKyMnMpB_C0JWnxrYXuKGRGHhx5WAN43RCmb2jRm2XBFCmYIsWn8WzCNxv_3vUF3JvMpvvF_vuDj89hVbIF0ES-bMJyXc3dFtkvtd5u2PQK7TzwIw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIlVcWt7dUsBIHLhku3Gch8VpRVktj1YVaqUekKLxS1TQtEqzauHET-A38kuYSTapQBwQlyiR7cjOPDwTz3wD8BytVmgKRn7M80hZdJGRIYtsknnyHpTXnrOR9_az-ZF6e5wer8DLPhemw4cYfrixZLT6mgX83IWda9BQrtg7VjrXN-CmyqRm4PzdD9fYUVqn6QAVruK8hxWayJ1h6N_Myt-t1HabmW3Ax36CXXTJ5_GiMWP77Q_sxv9cwW1YX5qfYtrxyx1Y8dVdWNtbHrDfgy_Tk_oSv4ratyVyOFddYOUE8SGxTpfmSA8CL5pPpyiw9qIvo9sIaiJzUpC6r5EPBDjCVZxyDYAr0eJB0MBwYjj2_ef3H7G9D0ez14ev5tGyIAORjvzIyFvSBw5VRlfjnTOJ9UVusthgHvh7B-PT1BtaEiNAYEiLHL0MdoKxI08zeQCr1VnlN0GECdrYOpvHTqlAL0hdQNQqc9IpIycj2O4pUy6l6qJk9EPS0GmRjODZ0EzywGvCyp8tuE-SkY2ppRzBw46i5XkH3FHKgvw38q9G8KKly9DQYTfLkilSMkXKg-nhnG-2_r3rU1g72J2V79_sv3sEtyRv_23YyzasNvXCPybjpTFPWib9BT0V7tI
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Airway+remodelling+and+inflammation+in+asthma+are+dependent+on+the+extracellular+matrix+protein+fibulin-1c&rft.jtitle=The+Journal+of+pathology&rft.au=Liu%2C+Gang&rft.au=Cooley%2C+Marion+A&rft.au=Nair%2C+Prema+M&rft.au=Donovan%2C+Chantal&rft.date=2017-12-01&rft.eissn=1096-9896&rft.volume=243&rft.issue=4&rft.spage=510&rft.epage=523&rft_id=info:doi/10.1002%2Fpath.4979&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3417&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3417&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3417&client=summon